Health care companies in the United States by one-year price change
How far the share price has moved over the last 52 weeks.
Moderna leads the 140 health care companies in the United States ranked by one-year price change, at +740%, ahead of Erasca (+387%) and Kodiak Sciences (+371%). Figures as of 21 Nov 2026, 05:50 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 140
- First
- Moderna+740%
- Median
- +22.1%
- Combined market value
- SAR 27.39T
- Countries
- 1
Market values as of .
United States▾
Health Care▾
All categories▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ModernaMRNA · Health Care | +740% | SAR 296B | SAR 731.54 | 2.17% down | 740% up | ||
| 2 | ErascaERAS · Health Care | +387% | SAR 17.9B | SAR 51.06 | 4.29% down | 387% up | ||
| 3 | Kodiak SciencesKOD · Health Care | +371% | SAR 23.8B | SAR 364.53 | 0.75% down | 371% up | ||
| 4 | Spyre TherapeuticsSYRE · Health Care | +302% | SAR 33.3B | SAR 350.65 | 4.26% down | 302% up | ||
| 5 | Twist BioscienceTWST · Health Care | +291% | SAR 26.4B | SAR 387.60 | 7.44% down | 291% up | ||
| 6 | Oruka TherapeuticsORKA · Health Care | +233% | SAR 24.4B | SAR 359.43 | 1.80% down | 233% up | ||
| 7 | VeradermicsMANE · Health Care | +230% | SAR 18.9B | SAR 448.38 | 3.92% down | 230% up | ||
| 8 | ImmunityBioIBRX · Health Care | +216% | SAR 24B | SAR 22.58 | 8.37% down | 216% up | ||
| 9 | 10x GenomicsTXG · Health Care | +213% | SAR 25.6B | SAR 194.33 | 9.72% down | 213% up | ||
| 10 | Definium TherapeuticsDFTX · Health Care | +176% | SAR 14.6B | SAR 106.32 | 3.87% down | 176% up | ||
| 11 | GlaukosGKOS · Health Care | +139% | SAR 52.7B | SAR 890.27 | 0.33% down | 139% up | ||
| 12 | Revolution MedicinesRVMD · Health Care | +125% | SAR 130.8B | SAR 604.74 | 1.11% up | 125% up | ||
| 13 | LifeStance Health GroupLFST · Health Care | +107% | SAR 19.7B | SAR 51.85 | 3.60% up | 107% up | ||
| 14 | Concentra Group Holdings ParentCON · Health Care | +105% | SAR 19.7B | SAR 156.96 | 0.94% up | 105% up | ||
| 15 | Dianthus TherapeuticsDNTH · Health Care | +105% | SAR 17.9B | SAR 317.19 | 0.33% down | 105% up | ||
| 16 | TG TherapeuticsTGTX · Health Care | +103% | SAR 35.9B | SAR 237.62 | 2.37% down | 103% up | ||
| 17 | Charles River Laboratories InternationalCRL · Health Care | +95.6% | SAR 56.5B | SAR 1,179.17 | 4.15% down | 96% up | ||
| 18 | Oscar HealthOSCR · Health Care | +94.1% | SAR 28.8B | SAR 92.77 | 5.50% down | 94% up | ||
| 19 | CG OncologyCGON · Health Care | +93.0% | SAR 26.6B | SAR 298.13 | 2.97% down | 93% up | ||
| 20 | ViatrisVTRS · Health Care | +90.1% | SAR 84.4B | SAR 73.64 | 1.26% down | 90% up | ||
| 21 | BrightSpring Health ServicesBTSG · Health Care | +85.1% | SAR 46.9B | SAR 235.93 | 1.77% down | 85% up | ||
| 22 | Praxis Precision MedicinesPRAX · Health Care | +83.1% | SAR 31.5B | SAR 1,127.06 | 3.37% down | 83% up | ||
| 23 | Lantheus HoldingsLNTH · Health Care | +82.9% | SAR 25.1B | SAR 383.03 | 0.00% | 83% up | ||
| 24 | Edgewise TherapeuticsEWTX · Health Care | +81.6% | SAR 16.4B | SAR 149.70 | 3.07% down | 82% up | ||
| 25 | Kymera TherapeuticsKYMR · Health Care | +80.8% | SAR 36.9B | SAR 432.59 | 3.42% down | 81% up | ||
| 26 | CenteneCNC · Health Care | +79.7% | SAR 118.5B | SAR 239.27 | 2.74% down | 80% up | ||
| 27 | Amneal PharmaceuticalsAMRX · Health Care | +79.0% | SAR 27.6B | SAR 79.23 | 1.26% down | 79% up | ||
| 28 | Royalty PharmaRPRX · Health Care | +74.0% | SAR 147.7B | SAR 256.79 | 1.08% up | 74% up | ||
| 29 | HumanaHUM · Health Care | +67.3% | SAR 175.7B | SAR 1,463.09 | 2.63% up | 67% up | ||
| 30 | IlluminaILMN · Health Care | +62.0% | SAR 109.4B | SAR 723.36 | 3.90% down | 62% up | ||
| 31 | PACS GroupPACS · Health Care | +56.5% | SAR 26B | SAR 163.83 | 1.49% up | 56% up | ||
| 32 | ExelixisEXEL · Health Care | +54.9% | SAR 59.2B | SAR 242.46 | 1.82% down | 55% up | ||
| 33 | RevvityRVTY · Health Care | +54.3% | SAR 60.8B | SAR 544.79 | 4.20% down | 54% up | ||
| 34 | HaemoneticsHAE · Health Care | +52.8% | SAR 20.5B | SAR 450.78 | 0.17% down | 53% up | ||
| 35 | Adaptive BiotechnologiesADPT · Health Care | +50.7% | SAR 17B | SAR 104.78 | 0.43% down | 51% up | ||
| 36 | Krystal BiotechKRYS · Health Care | +49.0% | SAR 34.3B | SAR 1,158.80 | 2.19% down | 49% up | ||
| 37 | TeleflexTFX · Health Care | +48.2% | SAR 24B | SAR 606.17 | 1.11% down | 48% up | ||
| 38 | West Pharmaceutical ServicesWST · Health Care | +46.3% | SAR 102B | SAR 1,464.21 | 1.61% down | 46% up | ||
| 39 | Protagonist TherapeuticsPTGX · Health Care | +45.2% | SAR 29.7B | SAR 455.43 | 2.11% down | 45% up | ||
| 40 | HeartflowHTFL · Health Care | +44.7% | SAR 15.4B | SAR 175.16 | 4.62% up | 45% up | ||
| 41 | Ligand PharmaceuticalsLGND · Health Care | +44.0% | SAR 21.5B | SAR 1,076.12 | 0.03% down | 44% up | ||
| 42 | ImmunovantIMVT · Health Care | +44.0% | SAR 24.7B | SAR 119.19 | 2.31% down | 44% up | ||
| 43 | Molina HealthcareMOH · Health Care | +43.6% | SAR 38.9B | SAR 744.26 | 2.43% down | 44% up | ||
| 44 | BiogenBIIB · Health Care | +41.0% | SAR 138.4B | SAR 936.34 | 1.00% up | 41% up | ||
| 45 | Becton, DickinsonBDX · Health Care | +40.4% | SAR 217.4B | SAR 798.24 | 0.05% up | 40% up | ||
| 46 | Travere TherapeuticsTVTX · Health Care | +39.2% | SAR 16.9B | SAR 176.32 | 2.69% down | 39% up | ||
| 47 | Labcorp HoldingsLH · Health Care | +38.9% | SAR 111.8B | SAR 1,377.29 | 0.47% down | 39% up | ||
| 48 | Baxter InternationalBAX · Health Care | +38.7% | SAR 49.3B | SAR 95.25 | 0.00% | 39% up | ||
| 49 | Guardant HealthGH · Health Care | +38.1% | SAR 74B | SAR 547.08 | 0.16% up | 38% up | ||
| 50 | Tenet HealthcareTHC · Health Care | +37.3% | SAR 78.6B | SAR 987.36 | 0.15% down | 37% up | ||
| 51 | Merck & CoMRK · Health Care | +35.9% | SAR 1.24T | SAR 501.65 | 0.69% up | 36% up | ||
| 52 | Quest DiagnosticsDGX · Health Care | +35.5% | SAR 106.6B | SAR 968.94 | 0.31% down | 35% up | ||
| 53 | Mirum PharmaceuticalsMIRM · Health Care | +34.6% | SAR 23.5B | SAR 360.63 | 0.65% up | 35% up | ||
| 54 | DexComDXCM · Health Care | +33.1% | SAR 111B | SAR 297.57 | 1.08% down | 33% up | ||
| 55 | Halozyme TherapeuticsHALO · Health Care | +32.3% | SAR 39.1B | SAR 342.70 | 1.82% down | 32% up | ||
| 56 | Gilead SciencesGILD · Health Care | +31.5% | SAR 774.4B | SAR 624.36 | 0.06% down | 31% up | ||
| 57 | BrukerBRKR · Health Care | +31.4% | SAR 32.3B | SAR 211.81 | 9.08% down | 31% up | ||
| 58 | AvantorAVTR · Health Care | +31.3% | SAR 37.7B | SAR 55.67 | 1.85% down | 31% up | ||
| 59 | Johnson & JohnsonJNJ · Health Care | +31.0% | SAR 2.44T | SAR 1,014.67 | 1.25% up | 31% up | ||
| 60 | DaVitaDVA · Health Care | +30.0% | SAR 38B | SAR 604.10 | 3.00% up | 30% up | ||
| 61 | Cardinal HealthCAH · Health Care | +30.0% | SAR 236.6B | SAR 1,023.45 | 0.17% up | 30% up | ||
| 62 | AmgenAMGN · Health Care | +30.0% | SAR 884B | SAR 1,634.30 | 0.15% down | 30% up | ||
| 63 | Eli LillyLLY · Health Care | +27.5% | SAR 4.5T | SAR 5,053.68 | 0.30% down | 28% up | ||
| 64 | Bristol-Myers SquibbBMY · Health Care | +26.1% | SAR 450.9B | SAR 220.59 | 0.79% up | 26% up | ||
| 65 | NateraNTRA · Health Care | +25.7% | SAR 148.7B | SAR 1,025.66 | 5.70% down | 26% up | ||
| 66 | Scholar Rock HoldingSRRK · Health Care | +25.3% | SAR 22B | SAR 180.56 | 4.45% down | 25% up | ||
| 67 | Belite BioBLTE · Health Care | +25.3% | SAR 19.4B | SAR 477.87 | 15.65% down | 25% up | ||
| 68 | ChemedCHE · Health Care | +24.8% | SAR 26.7B | SAR 2,058.04 | 0.50% down | 25% up | ||
| 69 | McKessonMCK · Health Care | +22.6% | SAR 463.2B | SAR 4,011.97 | 0.68% up | 23% up | ||
| 70 | Regeneron PharmaceuticalsREGN · Health Care | +22.2% | SAR 357.3B | SAR 3,453.97 | 0.19% down | 22% up | ||
| 71 | VaxcytePCVX · Health Care | +22.1% | SAR 32.9B | SAR 207.80 | 5.09% down | 22% up | ||
| 72 | Edwards LifesciencesEW · Health Care | +22.0% | SAR 219.7B | SAR 382.09 | 1.95% down | 22% up | ||
| 73 | Vertex PharmaceuticalsVRTX · Health Care | +22.0% | SAR 489.9B | SAR 1,932.10 | 1.08% down | 22% up | ||
| 74 | Elevance HealthELV · Health Care | +21.3% | SAR 319.7B | SAR 1,479.89 | 1.11% up | 21% up | ||
| 75 | AbbVieABBV · Health Care | +20.0% | SAR 1.9T | SAR 1,073.68 | 0.94% up | 20% up | ||
| 76 | Elanco Animal HealthELAN · Health Care | +18.2% | SAR 48.3B | SAR 96.56 | 2.09% down | 18% up | ||
| 77 | Bio-TechneTECH · Health Care | +18.2% | SAR 42.8B | SAR 272.62 | 0.04% down | 18% up | ||
| 78 | United TherapeuticsUTHR · Health Care | +17.7% | SAR 88.6B | SAR 2,081.07 | 0.78% down | 18% up | ||
| 79 | Mettler-Toledo InternationalMTD · Health Care | +17.4% | SAR 124.4B | SAR 6,253.30 | 2.27% down | 17% up | ||
| 80 | Thermo Fisher ScientificTMO · Health Care | +17.2% | SAR 930.7B | SAR 2,511.78 | 2.79% down | 17% up | ||
| 81 | Bio-Rad LaboratoriesBIO · Health Care | +16.0% | SAR 36.2B | SAR 1,346.41 | 2.34% down | 16% up | ||
| 82 | Agilent TechnologiesA · Health Care | +15.9% | SAR 180.2B | SAR 639.18 | 2.83% down | 16% up | ||
| 83 | WatersWAT · Health Care | +15.9% | SAR 324.7B | SAR 1,652.35 | 3.51% down | 16% up | ||
| 84 | Encompass HealthEHC · Health Care | +15.7% | SAR 49.2B | SAR 501.39 | 1.04% up | 16% up | ||
| 85 | Henry ScheinHSIC · Health Care | +15.5% | SAR 34.6B | SAR 313.33 | 1.51% down | 16% up | ||
| 86 | Rhythm PharmaceuticalsRYTM · Health Care | +14.8% | SAR 29.2B | SAR 421.52 | 3.80% down | 15% up | ||
| 87 | BridgeBio PharmaBBIO · Health Care | +14.8% | SAR 55.6B | SAR 285.23 | 2.75% down | 15% up | ||
| 88 | IncyteINCY · Health Care | +13.5% | SAR 87.7B | SAR 430.02 | 1.07% down | 14% up | ||
| 89 | MSA SafetyMSA · Health Care | +13.1% | SAR 24.6B | SAR 637.87 | 3.52% down | 13% up | ||
| 90 | BioMarin PharmaceuticalBMRN · Health Care | +12.3% | SAR 43.9B | SAR 226.63 | 1.64% down | 12% up | ||
| 91 | GRAILGRAL · Health Care | +12.1% | SAR 16.7B | SAR 372.34 | 5.33% down | 12% up | ||
| 92 | Align TechnologyALGN · Health Care | +12.0% | SAR 41B | SAR 582.12 | 2.82% down | 12% up | ||
| 93 | IQVIA HoldingsIQV · Health Care | +11.4% | SAR 152B | SAR 922.19 | 1.89% down | 11% up | ||
| 94 | PenumbraPEN · Health Care | +10.9% | SAR 47.2B | SAR 1,197.18 | 0.28% down | 11% up | ||
| 95 | Neurocrine BiosciencesNBIX · Health Care | +10.4% | SAR 57.2B | SAR 564.86 | 3.84% down | 10% up | ||
| 96 | Zimmer Biomet HoldingsZBH · Health Care | +10.1% | SAR 71.8B | SAR 379.28 | 0.36% down | 10% up | ||
| 97 | PfizerPFE · Health Care | +9.98% | SAR 585.9B | SAR 102.79 | 0.51% down | 10% up | ||
| 98 | Arrowhead PharmaceuticalsARWR · Health Care | +7.91% | SAR 21.9B | SAR 155.20 | 5.22% down | 8% up | ||
| 99 | Medpace HoldingsMEDP · Health Care | +7.12% | SAR 64.1B | SAR 2,290.44 | 3.70% down | 7% up | ||
| 100 | GE HealthCare TechnologiesGEHC · Health Care | +7.12% | SAR 136.8B | SAR 302.52 | 1.53% down | 7% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 3.7515 SAR).
Questions and answers
Which health care companies in the United States rank first by one-year price change?
Moderna (+740%), Erasca (+387%) and Kodiak Sciences (+371%) are the top three of the 140 health care companies in the United States ranked by one-year price change as of 21 Nov 2026, 05:50 UTC.
How many health care companies in the United States are in this ranking?
140 are ranked by one-year price change.
What are these health care companies in the United States worth together?
The 140 health care companies in the United States ranked by one-year price change have a combined market value of SAR 27.39T as of 21 Nov 2026, 05:50 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Health care companies in the United States by one-year price change”, data as of 21 November 2026. https://funkfolio.com/companies/sector/health-care?country=united-states&by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.